“Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses”, J of Skin, vol. 5, no. 3, pp. 203–227, May 2021, doi: 10.25251/skin.5.3.2.